VKTX- Viking Therapeutics, Inc.

Name: Viking Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Viking Therapeutics, Inc. (VKTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. VKTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Lian Brian	2.57M	$85.66M	-148,517
COO	Mancini Marianna	422.8K	$14.08M	-18,217
CFO	Zante Greg	212.2K	$7.07M	-21,217
Dir	Foehr Matthew W	148.0K	$4.93M	-
Dir	MacArtney Lawson	51.1K	$1.70M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 29, 2026	Mancini Marianna53	Chief Operating Officer	Sell	18,217	$33.47	$609,635.55	-4.1%	-	-
Jul 29, 2026	Zante Greg53	Chief Financial Officer	Sell	21,217	$33.47	$710,141.48	-9.1%	-	-
Jul 29, 2026	Lian Brian52	President &CEO	Sell	148,517	$33.32	$4,947,888.41	-5.5%	-	-
Jan 5, 2026	Mancini Marianna53	Chief Operating Officer	Sell	57,661	$32.98	$1,901,405.31	-3.3%	+5.6%	-
Jan 5, 2026	Lian Brian52	President &CEO	Sell	233,409	$32.96	$7,692,120.64	-2.2%	+5.6%	-
Jan 5, 2026	Zante Greg53	Chief Financial Officer	Sell	57,661	$32.90	$1,896,969.39	-6.7%	+5.6%	-
Jan 2, 2026	Foehr Matthew W72	Director	Sale+OE	16,000	$35.11	$561,694.40	-10.8%	-6.9%	-
Oct 28, 2025	Mancini Marianna53	Chief Operating Officer	Sell	6,185	$35.00	$216,491.70	-1.6%	-9.2%	-
Oct 28, 2025	Lian Brian52	President &CEO	Sell	38,989	$35.01	$1,364,923.01	-1.6%	-9.2%	-
Oct 28, 2025	Zante Greg53	Chief Financial Officer	Sell	6,185	$35.00	$216,480.57	-3.4%	-9.2%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC